Japan Exchange
22:06:13 2024-07-16 EDT
5-day change
1st Jan Change
6,037
JPY
-0.38%
+0.15%
+11.01%
<3:00 p.m. of January 31, 2018> Announcement of financial results for the third quarter ended December 31, 2017
January 26, 2018 at 05:54 am
Copyright ©2000-2018 AJINOMOTO CO.,INC. All rights reserved.
Ajinomoto Co. Inc. published this content on 26 January 2018 and is solely responsible for the information contained herein.26 January 2018 10:54:01 UTC .
Original document https://www.ajinomoto.com/en/ir/news/news6880324471560809851.html
Public permalink http://www.publicnow.com/view/531FE339FBC9849C433D413A7B50BA91BAA507C4
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on May 9, 2024.
07-02
CI
Transcript : Ajinomoto Co., Inc. - Special Call
06-30
Transcript : Ajinomoto Co., Inc., 2024 Earnings Call, May 09, 2024
05-09
Ajinomoto Co., Inc. announces an Equity Buyback for 12,500,000 shares, representing 2.44% for ¥50,000 million.
05-09
CI
Ajinomoto Co., Inc. authorizes a Buyback Plan.
05-08
CI
Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
03-26
TechMagic, Inc. announced that it has received funding from a group of investors
03-26
CI
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
03-26
CI
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
03-12
MT
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
03-08
CI
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
03-06
CI
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
02-20
CI
Transcript : Ajinomoto Co., Inc., Q3 2024 Earnings Call, Feb 06, 2024
02-06
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
01-30
CI
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
01-17
MT
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
01-17
MT
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
01-16
CI
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
01-05
CI
Transcript : Ajinomoto Co., Inc. - Special Call
12-04
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
11-13
RE
Ajinomoto Co., Inc. announces an Equity Buyback for 10,000,000 shares, representing 1.92% for ¥40,000 million.
11-13
CI
Ajinomoto Co., Inc. authorizes a Buyback Plan.
11-12
CI
China Trade Report, Wall Street Cues Blunt Asian Stock Markets
11-07
MT
Japan's Nikkei falls after sharp gains, Treasury yields rise weighs
11-06
RE
Transcript : Ajinomoto Co., Inc., Q2 2024 Earnings Call, Nov 07, 2023
11-06
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Ajinomoto Co., Inc. specializes in the production and marketing of food and pharmaceutical products. Net sales break down by activity as follows:
- sale of food products (57%): seasonings (brands AJI-No-Moto and Hon-Dashi), mayonnaise (Pure Select), instant noodles, beverages, etc.;
- sale of frozen products (19.7%);
- other (23.3%).
More about the company
Last Close Price
6,060
JPY
Average target price
6,255
JPY
Spread / Average Target
+3.21%
Consensus
1st Jan change
Capi.
+11.01% 20.01B -5.01% 273B -9.11% 86.32B -0.48% 41B -11.20% 39.21B +1.89% 38.21B -3.44% 35.09B -10.61% 31.35B -1.97% 30.03B +4.10% 23.79B
Other Food Processing
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
AJINOMOTO CO., INC. 
